HuGE Literature Finder
Records 1-30
|
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant.
Nature communications 2019 Nov 10 (1): 5061. Deng Qipan, Hu Hui, Yu Xinfang, Liu Shuanglin, Wang Lei, Chen Weiqun, Zhang Chi, Zeng Zhaoyang, Cao Ya, Xu-Monette Zijun Y, Li Ling, Zhang Mingzhi, Rosenfeld Steven, Bao Shideng, Hsi Eric, Young Ken H, Lu Zhongxin, Li Yo |
|
Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort.
BMC medical genetics 2019 Sep 20 (1): 150. Akter Hosneara, Sultana Nasima, Martuza Nazrana, Siddiqua Aaysha, Dity Nushrat Jahan, Rahaman Md Atikur, Samara Bisan, Sayeed Ahmed, Basiruzzaman Mohammed, Rahman Mohammad Mizanur, Rashidul Hoq Md, Amin Md Robed, Baqui Md Abdul, Woodbury-Smith Marc, Uddin K M Furkan, Islam Syed S, Awwal Rayhana, Berdiev Bakhrom K, Uddin Mohamm |
|
[Prognostic role of p53 gene polymorphism in risk assessment of anthracycline-induced cardiotoxicity].
Kardiologiia 2019 Aug 59 (7S): 15-22. Shilov S N, Teplyakov A T, Popova A A, Berezikova E N, Neupokoeva M N, Grakova E V, Valeeva A M, Tuleutaev Sh |
|
Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
Gynecologic oncology 2019 Aug . Ong Pei Yi, Poon Song Ling, Tan Kien Thiam, Putti Thomas Choudary, Ow Samuel Guan Wei, Chen Shu-Jen, Chen Chien-Hong, Lee Soo-Ch |
|
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years.
Breast cancer research : BCR 2019 May 21 (1): 58. Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
|
Prevalence and Clinical Impact of TP53 Germline Mutations in Chinese Women with Breast Cancer.
International journal of cancer 2019 May . Sheng Shuyan, Xu Ye, Guo Yonghai, Yao Lu, Hu Li, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
Breast cancer research and treatment 2019 Apr . Bernstein-Molho Rinat, Singer Amihood, Laitman Yael, Netzer Iris, Zalmanoviz Shelley, Friedman Eit |
|
Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer.
Journal of cancer research and clinical oncology 2019 Feb . Chen Xinyi, Guo Yonghai, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt |
|
Genomic alterations associated with HER2+?breast cancer risk and clinical outcome in response to trastuzumab.
Molecular biology reports 2019 Feb 46 (1): 823-831. Singla Heena, Kaur Raman Preet, Shafi Gowhar, Vashistha Rajesh, Banipal Raja Paramjeet Singh, Kumar Vinod, Munshi Anja |
|
Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors.
Breast cancer research and treatment 2019 Feb . Aceto Gitana Maria, Awadelkarim Khalid Dafaallah, Di Nicola Marta, Moscatello Carmelo, Pantalone Mattia Russel, Verginelli Fabio, Elwali Nasr Eldin, Mariani-Costantini Rena |
|
Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.
BMC cancer 2019 Feb 19 (1): 118. Gallardo-Alvarado Lenny N, Tusié-Luna María Teresa, Tussié-Luna María Isabel, Díaz-Chávez José, Segura Yayoi X, Bargallo-Rocha Enrique, Villarreal Cynthia, Herrera-Montalvo Luis A, Herrera-Medina Enrique M, Cantu-de Leon David |
|
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.
International journal of cancer 2019 Jan 144 (2): 281-289. Li Jun-Yan, Jing Ruilin, Wei Hongyi, Wang Minghao, Xiaowei Qi, Liu Haoxi, Jian Liu, Ou Jiang-Hua, Jiang Wei-Hua, Tian Fu-Guo, Sheng Yuan, Li Heng-Yu, Xu Hong, Zhang Rui-Shan, Guan Ai-Hua, Liu Ke, Jiang Hong-Chuan, Ren Yu, He Jian-Jun, Huang Weiwei, Liao Ning, Cai Xiangjun, Ming Jia, Ling Rui, Xu Yan, Hu Chun-Yan, Zhang Jianguo, Guo Baoliang, Ouyang Lizhi, Shuai Ping, Liu Zhenzhen, Zhong Ling, Zeng Zhen, Zhang Ting, Xuan Zhaoling, Tan Xuanni, Liang Junbin, Pan Qinwen, Chen Li, Zhang Fan, Fan Lin-Jun, Zhang Yi, Yang Xinhua, BoLi Jing, Chen Chongjian, Jiang J |
|
Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.
International journal of molecular sciences 2019 Jan 20 (3): . Lopez Gianluca, Costanza Jole, Colleoni Matteo, Fontana Laura, Ferrero Stefano, Miozzo Monica, Fusco Nico |
|
Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
PloS one 2019 14 (8): e0220727. Pouladi Nasser, Abdolahi Sepehr, Farajzadeh Davoud, Hosseinpour Feizi Mohammad A |
|
The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype.
PloS one 2019 14 (2): e0211734. Hebert-Magee Shantel, Yu Han, Behring Michael, Jadhav Trafina, Shanmugam Chandrakumar, Frost Andra, Eltoum Isam-Eldin, Varambally Sooryanarayana, Manne Upend |
|
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Journal of hematology & oncology 2018 Oct 11 (1): 124. Liang Xu, Briaux Adrien, Becette Véronique, Benoist Camille, Boulai Anais, Chemlali Walid, Schnitzler Anne, Baulande Sylvain, Rivera Sofia, Mouret-Reynier Marie-Ange, Bouvet Laurence Venat, De La Motte Rouge Thibaut, Lemonnier Jérôme, Lerebours Florence, Callens Céli |
|
No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
European journal of medical research 2018 Oct 23 (1): 47. Hao Weiming, Xu Xia, Shi Haifeng, Zhang Chiyu, Chen Xiaoxia |
|
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Cancer science 2018 Oct . Gaowa Siqin, Futamura Manabu, Tsuneki Masayuki, Kamino Hiroki, Tajima Jesse Y, Mori Ryutaro, Arakawa Hirofumi, Yoshida Kazuhi |
|
The prognostic effects of somatic mutations in ER-positive breast cancer.
Nature communications 2018 Sep 9 (1): 3476. Griffith Obi L, Spies Nicholas C, Anurag Meenakshi, Griffith Malachi, Luo Jingqin, Tu Dongsheng, Yeo Belinda, Kunisaki Jason, Miller Christopher A, Krysiak Kilannin, Hundal Jasreet, Ainscough Benjamin J, Skidmore Zachary L, Campbell Katie, Kumar Runjun, Fronick Catrina, Cook Lisa, Snider Jacqueline E, Davies Sherri, Kavuri Shyam M, Chang Eric C, Magrini Vincent, Larson David E, Fulton Robert S, Liu Shuzhen, Leung Samuel, Voduc David, Bose Ron, Dowsett Mitch, Wilson Richard K, Nielsen Torsten O, Mardis Elaine R, Ellis Matthew |
|
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
JAMA oncology 2018 Aug . Lu Hsiao-Mei, Li Shuwei, Black Mary Helen, Lee Shela, Hoiness Robert, Wu Sitao, Mu Wenbo, Huether Robert, Chen Jefferey, Sridhar Srijani, Tian Yuan, McFarland Rachel, Dolinsky Jill, Tippin Davis Brigette, Mexal Sharon, Dunlop Charles, Elliott Aar |
|
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
|
Inherited Breast Cancer in Nigerian Women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Aug JCO2018783977. Zheng Yonglan, Walsh Tom, Gulsuner Suleyman, Casadei Silvia, Lee Ming K, Ogundiran Temidayo O, Ademola Adeyinka, Falusi Adeyinka G, Adebamowo Clement A, Oluwasola Abideen O, Adeoye Adewumi, Odetunde Abayomi, Babalola Chinedum P, Ojengbede Oladosu A, Odedina Stella, Anetor Imaria, Wang Shengfeng, Huo Dezheng, Yoshimatsu Toshio F, Zhang Jing, Felix Gabriela E S, King Mary-Claire, Olopade Olufunmilayo |
|
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Breast cancer research : BCR 2018 Aug 20 (1): 88. Liang Xu, Vacher Sophie, Boulai Anais, Bernard Virginie, Baulande Sylvain, Bohec Mylene, Bièche Ivan, Lerebours Florence, Callens Céli |
|
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Breast cancer research and treatment 2018 Jun . Van Swearingen Amanda E D, Siegel Marni B, Deal Allison M, Sambade Maria J, Hoyle Alan, Hayes D Neil, Jo Heejoon, Little Paul, Dees Elizabeth Claire, Muss Hyman, Jolly Trevor, Zagar Timothy M, Patel Nirali, Miller C Ryan, Parker Joel S, Smith J Keith, Fisher Julie, Shah Nikita, Nabell Lisle, Nanda Rita, Dillon Patrick, Abramson Vandana, Carey Lisa A, Anders Carey |
|
The 72Pro Variant of the Tumor Protein 53 Is Associated with an Increased Breast Cancer Risk in the Moroccan Population.
Pathobiology : journal of immunopathology, molecular and cellular biology 2018 Jun 1-7. Ayoubi Salah Eddine, Elkarroumi Mohamed, El Khachibi Meryam, Hassani Idrissi Hind, Ayoubi Hasnaa, Ennachit Simohamed, Arazzakou Mounia, Nadifi Sella |
|
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
PLoS genetics 2018 Apr 14 (4): e1007355. Paulo Paula, Maia Sofia, Pinto Carla, Pinto Pedro, Monteiro Augusta, Peixoto Ana, Teixeira Manuel |
|
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes.
British journal of cancer 2018 Mar . Gy?rffy Balázs, Pongor L?rinc, Bottai Giulia, Li Xiaotong, Budczies Jan, Szabó András, Hatzis Christos, Pusztai Lajos, Santarpia Libe |
|
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
Journal of the National Cancer Institute 2018 Feb . Weigelt Britta, Bi Rui, Kumar Rahul, Blecua Pedro, Mandelker Diana L, Geyer Felipe C, Pareja Fresia, James Paul A, , Couch Fergus J, Eccles Diana M, Blows Fiona, Pharoah Paul, Li Anqi, Selenica Pier, Lim Raymond S, Jayakumaran Gowtham, Waddell Nic, Shen Ronglai, Norton Larry, Wen Hannah Y, Powell Simon N, Riaz Nadeem, Robson Mark E, Reis-Filho Jorge S, Chenevix-Trench Georg |
|
Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population.
Technology in cancer research & treatment 2018 Jan 17 1533033818819841. Chen Fei-Yu, Wang Hao, Li Hui, Hu Xue-Li, Dai Xu, Wang Shou-Man, Yan Guo-Jiao, Jiang Ping-Lan, Hu Yuan-Ping, Huang Juan, Tang Li- |
|
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
Nature communications 2018 10 9 (1): 4181. Pitt Jason J, Riester Markus, Zheng Yonglan, Yoshimatsu Toshio F, Sanni Ayodele, Oluwasola Olayiwola, Veloso Artur, Labrot Emma, Wang Shengfeng, Odetunde Abayomi, Ademola Adeyinka, Okedere Babajide, Mahan Scott, Leary Rebecca, Macomber Maura, Ajani Mustapha, Johnson Ryan S, Fitzgerald Dominic, Grundstad A Jason, Tuteja Jigyasa H, Khramtsova Galina, Zhang Jing, Sveen Elisabeth, Hwang Bryce, Clayton Wendy, Nkwodimmah Chibuzor, Famooto Bisola, Obasi Esther, Aderoju Victor, Oludara Mobolaji, Omodele Folusho, Akinyele Odunayo, Adeoye Adewunmi, Ogundiran Temidayo, Babalola Chinedum, MacIsaac Kenzie, Popoola Abiodun, Morrissey Michael P, Chen Lin S, Wang Jiebiao, Olopade Christopher O, Falusi Adeyinka G, Winckler Wendy, Haase Kerstin, Van Loo Peter, Obafunwa John, Papoutsakis Dimitris, Ojengbede Oladosu, Weber Barbara, Ibrahim Nasiru, White Kevin P, Huo Dezheng, Olopade Olufunmilayo I, Barretina Jor |
|
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Clinical genetics 2018 03 93 (3): 595-602. Pelttari L M, Shimelis H, Toiminen H, Kvist A, Törngren T, Borg Å, Blomqvist C, Bützow R, Couch F, Aittomäki K, Nevanlinna |
|
Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
PloS one 2018 13 (9): e0203495. Li Guoli, Guo Xinwu, Chen Ming, Tang Lili, Jiang Hui, Day Julia X, Xie Yueliang, Peng Limin, Xu Xunxun, Li Jinliang, Wang Shouman, Xiao Zhi, Dai Lizhong, Wang J |
|
SNPing away at mutant p53 activities.
Genes & development 2018 02 32 (3-4): 195-196. Ortiz Guadalupe J, Lozano Guillermi |
|
Use of deep whole-genome sequencing data to identify structure risk variants in breast cancer susceptibility genes.
Human molecular genetics 2018 03 27 (5): 853-859. Guo Xingyi, Shi Jiajun, Cai Qiuyin, Shu Xiao-Ou, He Jing, Wen Wanqing, Allen Jamie, Pharoah Paul, Dunning Alison, Hunter David J, Kraft Peter, Easton Douglas F, Zheng Wei, Long Jiro |
|
Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.
BMC cancer 2018 01 18 (1): 83. Park Ji Soo, Lee Seung-Tae, Nam Eun Ji, Han Jung Woo, Lee Jung-Yun, Kim Jieun, Kim Tae Il, Park Hyung Se |
|
Genetic alterations in sporadic triple negative breast cancer.
Breast (Edinburgh, Scotland) 2017 Dec 38 30-38. Pop Laura-Ancuta, Cojocneanu-Petric Roxana-Maria, Pileczki Valentina, Morar-Bolba Gabriela, Irimie Alexandru, Lazar Vladimir, Lombardo Claudio, Paradiso Angelo, Berindan-Neagoe Ioa |
|
Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.
Genes, chromosomes & cancer 2017 Nov . Oltmann Johanna, Heselmeyer-Haddad Kerstin, Hernandez Leanora S, Meyer Rüdiger, Torres Irianna, Hu Yue, Doberstein Natalie, Killian J Keith, Petersen David, Zhu Y Jack, Edelman Daniel C, Meltzer Paul S, Schwartz Russell, Gertz E Michael, Schäffer Alejandro A, Auer Gert, Habermann Jens K, Ried Thom |
|
Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population.
Pathobiology : journal of immunopathology, molecular and cellular biology 2017 Nov . Habyarimana Thierry, Attaleb Mohammed, Mugenzi Pacifique, Mazarati Jean Baptiste, Bakri Youssef, El Mzibri Mohamm |
|
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
Breast cancer research and treatment 2017 Nov 166 (1): 179-184. Santa-Maria Cesar A, Kruse Megan, Raska Paola, Weiss Mia, Swoboda April, Mutonga Martin B, Abraham Jame, Jain Sarika, Nanda Rita, Montero Alberto |
|
The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
BMC cancer 2017 Nov 17 (1): 758. Isakova Jainagul, Talaibekova Elnura, Aldasheva Nazira, Vinnikov Denis, Aldashev Alm |
|
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.
Biological research 2017 Oct 50 (1): 35. Jara Lilian, Morales Sebastian, de Mayo Tomas, Gonzalez-Hormazabal Patricio, Carrasco Valentina, Godoy Ra |
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
|
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Sep . Lavigne Marion, Menet Emmanuelle, Tille Jean-Christophe, Lae Marick, Fuhrmann Laetitia, Bonneau Claire, Deniziaut Gabrielle, Melaabi Samia, Ng Charlotte C K, Marchiò Caterina, Rouzier Roman, Bièche Ivan, Vincent-Salomon An |
|
First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Aug JCO2017733246. Goetz Matthew P, Suman Vera J, Reid Joel M, Northfelt Don W, Mahr Michael A, Ralya Andrew T, Kuffel Mary, Buhrow Sarah A, Safgren Stephanie L, McGovern Renee M, Black John, Dockter Travis, Haddad Tufia, Erlichman Charles, Adjei Alex A, Visscher Dan, Chalmers Zachary R, Frampton Garrett, Kipp Benjamin R, Liu Minetta C, Hawse John R, Doroshow James H, Collins Jerry M, Streicher Howard, Ames Matthew M, Ingle James |
|
p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Familial cancer 2017 Jul . Macedo Gabriel S, Vieira Igor Araujo, Vianna Fernanda Salles Luiz, Alemar Barbara, Giacomazzi Juliana, Brandalize Ana Paula Carneiro, Caleffi Maira, Volc Sahlua Miguel, de Campos Reis Galvão Henrique, Palmero Edenir Inez, Achatz Maria Isabel, Ashton-Prolla Patric |
|
Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
Breast cancer research and treatment 2017 Jun . Yang Xiaohong R, Devi Beena C R, Sung Hyuna, Guida Jennifer, Mucaki Eliseos J, Xiao Yanzi, Best Ana, Garland Lisa, Xie Yi, Hu Nan, Rodriguez-Herrera Maria, Wang Chaoyu, Jones Kristine, Luo Wen, Hicks Belynda, Tang Tieng Swee, Moitra Karobi, Rogan Peter K, Dean Micha |
|
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Mar . Pang Jia-Min B, Savas Peter, Fellowes Andrew P, Mir Arnau Gisela, Kader Tanjina, Vedururu Ravikiran, Hewitt Chelsee, Takano Elena A, Byrne David J, Choong David Yh, Millar Ewan Ka, Lee C Soon, O'Toole Sandra A, Lakhani Sunil R, Cummings Margaret C, Mann G Bruce, Campbell Ian G, Dobrovic Alexander, Loi Sherene, Gorringe Kylie L, Fox Stephen |
|
Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study.
Cancer investigation 2017 Mar 1-15. Al-Eitan Laith N, Jamous Reem I, Khasawneh Rame |
|
Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.
Oncotarget 2017 Mar . Kim Ji-Yeon, Lee Eunjin, Park Kyunghee, Park Woong-Yang, Jung Hae Hyun, Ahn Jin Seok, Im Young-Hyuck, Park Yeon H |
|
The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China.
Oncotarget 2017 Mar . Bai Xianan, Xie Jingjing, Sun Shanshan, Zhang Xianyu, Jiang Yongdong, Pang |
|
Identification of frequent somatic mutations in inflammatory breast cancer.
Breast cancer research and treatment 2017 Feb . Matsuda Naoko, Lim Bora, Wang Ying, Krishnamurthy Savitri, Woodward Wendy, Alvarez Ricardo H, Lucci Anthony, Valero Vicente, Reuben James M, Meric-Bernstam Funda, Ueno Naoto |
|
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.
Oncotarget 2017 Feb . Fagerholm Rainer, Khan Sofia, Schmidt Marjanka K, García-Closas Montserrat, Heikkilä Päivi, Saarela Jani, Beesley Jonathan, Jamshidi Maral, Aittomäki Kristiina, Liu Jianjun, Ali H Raza, Andrulis Irene L, Beckmann Matthias W, Behrens Sabine, Blows Fiona M, Brenner Hermann, Chang-Claude Jenny, Couch Fergus J, Czene Kamila, Fasching Peter A, Figueroa Jonine, Floris Giuseppe, Glendon Gord, Guo Qi, Hall Per, Hallberg Emily, Hamann Ute, Holleczek Bernd, Hooning Maartje J, Hopper John L, Jager Agnes, Kabisch Maria, , Keeman Renske, Kosma Veli-Matti, Lambrechts Diether, Lindblom Annika, Mannermaa Arto, Margolin Sara, Provenzano Elena, Shah Mitul, Southey Melissa C, Dennis Joe, Lush Michael, Michailidou Kyriaki, Wang Qin, Bolla Manjeet K, Dunning Alison M, Easton Douglas F, Pharoah Paul D P, Chenevix-Trench Georgia, Blomqvist Carl, Nevanlinna He |
|
Increased breast cancer risk with HABP1/p32/gC1qR genetic polymorphism rs2285747 and its upregulation in northern Chinese women.
Oncotarget 2017 Jan . Jiang Yongdong, Wu Hao, Liu Jing, Chen Yanbo, Xie Jingjing, Zhao Yashuang, Pang |
|
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.
Oncotarget 2017 Jan . Fancello Laura, Kampen Kim R, Hofman Isabel Jf, Verbeeck Jelle, De Keersmaecker K |
|
Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.
Carcinogenesis 2017 05 38 (5): 511-518. Han Mi-Ryung, Zheng Wei, Cai Qiuyin, Gao Yu-Tang, Zheng Ying, Bolla Manjeet K, Michailidou Kyriaki, Dennis Joe, Wang Qin, Dunning Alison M, Brennan Paul, Chen Shou-Tung, Choi Ji-Yeob, Hartman Mikael, Ito Hidemi, Lophatananon Artitaya, Matsuo Keitaro, Miao Hui, Muir Kenneth, Sangrajrang Suleeporn, Shen Chen-Yang, Teo Soo Hwang, Tseng Chiu-Chen, Wu Anna H, Yip Cheng Har, Kang Daehee, Xiang Yong-Bing, Easton Douglas F, Shu Xiao-Ou, Long Jiro |
|
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
|
The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome.
PloS one 2017 12 (8): e0182444. Sadighi Sanambar, Zokaasadi Mohammad, Kasaeian Amir, Maghsudi Somaye, Jahanzad Issa, Kamranzadeh Fumani Hose |
|
Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk.
Human mutation 2016 Dec . Samuel Nardin, Id Said Badr, Guha Tanya, Novokmet Ana, Li Weili, Silwal-Pandit Laxmi, Børrsen-Dale Anne-Lise, Langerød Anita, Hudson Thomas J, Malkin Dav |
|
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Oncotarget 2016 Nov . Ping Zheng, Siegal Gene P, Harada Shuko, Eltoum Isam-Eldin, Youssef Mariam, Shen Tiansheng, He Jianbo, Huang Yingjie, Chen Dongquan, Li Yiping, Bland Kirby I, Chang Helena R, Shen Dej |
|
TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Breast cancer (Tokyo, Japan) 2016 Nov . Hossain Amir, Murshid Gazi Md Monjur, Zilani Md Nazmul Hasan, Islam Fahrima, Sultana Razia, Sultana Tamanna, Hossain Md Golam, Rahman Md Mustafiz |
|
Clinical outcomes based on multigene profiling in metastatic breast cancer patients.
Oncotarget 2016 Oct . Basho Reva K, Gagliato Debora de Melo, Ueno Naoto T, Wathoo Chetna, Chen Huiqin, Shariati Maryam, Wei Caimiao, Alvarez Ricardo H, Moulder Stacy L, Sahin Aysegul A, Roy-Chowdhuri Sinchita, Chavez-MacGregor Mariana, Litton Jennifer K, Valero Vincent, Luthra Raja, Zeng Jia, Shaw Kenna R, Mendelsohn John, Mills Gordon B, Tripathy Debu, Meric-Bernstam Fun |
|
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Oct . Geyer Felipe C, Berman Samuel H, Marchiò Caterina, Burke Kathleen A, Guerini-Rocco Elena, Piscuoglio Salvatore, Ng Charlotte Ky, Pareja Fresia, Wen Hannah Y, Hodi Zoltan, Schnitt Stuart J, Rakha Emad A, Ellis Ian O, Norton Larry, Weigelt Britta, Reis-Filho Jorge |
|
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.
Oncotarget 2016 Oct 7 (41): 66790-66808. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Grzybowska E |
|
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.
Breast cancer research : BCR 2016 Oct 18 (1): 98. Muranen Taru A, Blomqvist Carl, Dörk Thilo, Jakubowska Anna, Heikkilä Päivi, Fagerholm Rainer, Greco Dario, Aittomäki Kristiina, Bojesen Stig E, Shah Mitul, Dunning Alison M, Rhenius Valerie, Hall Per, Czene Kamila, Brand Judith S, Darabi Hatef, Chang-Claude Jenny, Rudolph Anja, Nordestgaard Børge G, Couch Fergus J, Hart Steven N, Figueroa Jonine, García-Closas Montserrat, Fasching Peter A, Beckmann Matthias W, Li Jingmei, Liu Jianjun, Andrulis Irene L, Winqvist Robert, Pylkäs Katri, Mannermaa Arto, Kataja Vesa, Lindblom Annika, Margolin Sara, Lubinski Jan, Dubrowinskaja Natalia, Bolla Manjeet K, Dennis Joe, Michailidou Kyriaki, Wang Qin, Easton Douglas F, Pharoah Paul D P, Schmidt Marjanka K, Nevanlinna He |
|
TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Familial cancer 2016 Oct . Andrade Raissa Coelho, Dos Santos Anna Claudia Evangelista, de Aguirre Neto Joaquim Caetano, Nevado Julián, Lapunzina Pablo, Vargas Fernando Reg |
|
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
International journal of molecular sciences 2016 Sep 17 (10): . Mu Zhaomei, Benali-Furet Naoual, Uzan Georges, Znaty Anaëlle, Ye Zhong, Paolillo Carmela, Wang Chun, Austin Laura, Rossi Giovanna, Fortina Paolo, Yang Hushan, Cristofanilli Massi |
|
Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
International journal of cancer 2016 Sep . Kraus Cornelia, Hoyer Juliane, Vasileiou Georgia, Wunderle Marius, Lux Michael P, Fasching Peter A, Krumbiegel Mandy, Uebe Steffen, Reuter Miriam, Beckmann Matthias W, Reis And |
|
Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Sep . Geurts-Giele Willemina R R, van Verschuer Victorien M T, van Deurzen Carolien H M, van Diest Paul J, Pedrosa Rute M S M, Collée J Margriet, Koppert Linetta B, Seynaeve Caroline, Dinjens Winand N |
|
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.
Oncotarget 2016 Sep . Darb-Esfahani Silvia, Denkert Carsten, Stenzinger Albrecht, Salat Christoph, Sinn Bruno, Schem Christian, Endris Volker, Klare Peter, Schmitt Wolfgang, Blohmer Jens-Uwe, Weichert Wilko, Möbs Markus, Tesch Hans, Kümmel Sherko, Sinn Peter, Jackisch Christian, Dietel Manfred, Reimer Toralf, Loi Sherene, Untch Michael, von Minckwitz Gunter, Nekljudova Valentina, Loibl Sibyl |
|
[Association between genetic variants in p53 binding sites and risks of breast cancer in Chinese population].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2016 Aug 37 (8): 1063-8. Chen W, Zhang Y, Zhu Y, Yang Y, Gong Y J, Miao X P, Zhong |
|
DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women.
Oncotarget 2016 Aug . Fu Zhenkun, Chen Shuang, Liu Shengwei, Han Shaoli, Gao Xiang, Li Dalin, Li Dianj |
|
Improving the performance of somatic mutation identification by recovering circulating tumor DNA mutations.
Cancer research 2016 Aug . Fu Yu, Jovelet Cecile, Filleron Thomas, Pedrero Marion, Motté Nelly, Boursin Yannick, Luo Yufei, Massard Christophe, Campone Mario, Levy Christelle, Dieras Veronique, Bachelot Thomas, Garrabey Julie, Soria Jean-Charles, Lacroix Ludovic, Andre Fabrice, Lefebvre Celi |
|
Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.
Clinical laboratory 2016 Jul 62 (7): 1303-1308. Pedram Negar, Pouladi Nasser, Feizi Mohammad A Hosseinpour, Montazeri Vahid, Sakhinia Ebrahim, Estiar Mehrdad |
|
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.
Breast cancer research and treatment 2016 Jul . Kotoula Vassiliki, Karavasilis Vasilios, Zagouri Flora, Kouvatseas George, Giannoulatou Eleni, Gogas Helen, Lakis Sotiris, Pentheroudakis George, Bobos Mattheos, Papadopoulou Kyriaki, Tsolaki Eleftheria, Pectasides Dimitrios, Lazaridis Georgios, Koutras Angelos, Aravantinos Gerasimos, Christodoulou Christos, Papakostas Pavlos, Markopoulos Christos, Zografos George, Papandreou Christos, Fountzilas Geor |
|
Functional SNP in stem of mir-146a affect Her2 status and breast cancer survival.
Cancer biomarkers : section A of Disease markers 2016 Jul . Mehskat Mahboobeh, Tanha Hamzeh Mesrian, Naeini Marjan Mojtabavi, Ghaedi Kamran, Sanati Mohammad H, Meshkat Marzieh, Bagheri Fatem |
|
Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen.
Oncotarget 2016 May . Jansen Maurice Phm, Martens John Wm, Helmijr Jean Ca, Beaufort Corine M, van Marion Ronald, Krol Niels Mg, Monkhorst Kim, Trapman-Jansen Anita Mac, Meijer-van Gelder Marion E, Weerts Marjolein Ja, Ramirez-Ardila Diana E, Dubbink Hendrikus Jan, Foekens John A, Sleijfer Stefan, Berns Els M |
|
Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
Clinical breast cancer 2016 May . Nakauchi Chiaki, Kagara Naofumi, Shimazu Kenzo, Shimomura Atsushi, Naoi Yasuto, Shimoda Masafumi, Kim Seung Jin, Noguchi Shinzabu |
|
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 May 34 (13): 1455-9. Thompson Ella R, Rowley Simone M, Li Na, McInerny Simone, Devereux Lisa, Wong-Brown Michelle W, Trainer Alison H, Mitchell Gillian, Scott Rodney J, James Paul A, Campbell Ian |
|
Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
Virchows Archiv : an international journal of pathology 2016 May . Leo Fabian, Bartels Stephan, Mägel Lavinia, Framke Theodor, Büsche Guntram, Jonigk Danny, Christgen Matthias, Lehmann Ulrich, Kreipe Ha |
|
Commentary regarding Schayek et al., entitled "The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil".
Cancer genetics 2016 Apr . Sales Luiz Vianna Fernanda, Alemar Barbara, Achatz Maria Isabel, Camey Suzi Alves, Ashton-Prolla Patric |
|
Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Apr . Dalin Martin G, Desrichard Alexis, Katabi Nora, Makarov Vladimir, Walsh Logan A, Lee Ken-Wing, Wang Qingguo, Armenia Joshua, West Lyndsay, Dogan Snjezana, Wang Lu, Ramaswami Deepa, Ho Alan L, Ganly Ian, Solit David, Berger Michael F, Schultz Nikolaus, Reis-Filho Jorge S, Chan Timothy A, Morris Luc |
|
p53 expression and relationship with MDM2 amplification in breast carcinomas.
Annals of diagnostic pathology 2016 Apr 21 29-34. Buyukpinarbasili Nur, Gucin Zuhal, Ersoy Yeliz Emine, ?lbak Ayca, Kadioglu Huseyin, Muslumanoglu Mahm |
|
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.
Experimental and molecular pathology 2016 Apr 100 (3): 421-425. Muller Kristen E, Marotti Jonathan D, de Abreu Francine B, Peterson Jason D, Miller Todd W, Chamberlin Mary D, Tsongalis Gregory J, Tafe Laura |
|
The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil.
Cancer genetics 2016 Apr . Schayek Hagit, De Marco Luiz, Starinsky-Elbaz Sigal, Rossette Mariana, Laitman Yael, Bastos-Rodrigues Luciana, Lopes da Silva Filho Agnaldo, Friedman Eit |
|
Comparative genomic analysis of primary tumors and metastases in breast cancer.
Oncotarget 2016 Mar . Bertucci François, Finetti Pascal, Guille Arnaud, Adélaïde José, Garnier Séverine, Carbuccia Nadine, Monneur Audrey, Charafe-Jauffret Emmanuelle, Goncalves Anthony, Viens Patrice, Birnbaum Daniel, Chaffanet M |
|
Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.
The International journal of biological markers 2016 Mar 0. Krivokuca Ana M, Cavic Milena R, Malisic Emina J, Rakobradovic Jelena D, Kolarevic-Ivankovic Daniela, Tomasevic Zorica I, Brankovic-Magic Mirjana |
|
Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
Genetics and molecular research : GMR 2016 Feb 15 (1): . Almeida B C, Kleine J P F O, Camargo-Kosugi C M, Lisboa M R, França C N, França J P, Silva I D C |
|
MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations.
American journal of human genetics 2016 Feb . Hua Xing, Hyland Paula L, Huang Jing, Song Lei, Zhu Bin, Caporaso Neil E, Landi Maria Teresa, Chatterjee Nilanjan, Shi Jianx |
|
Whole exome sequencing of rare aggressive breast cancer histologies.
Breast cancer research and treatment 2016 Feb . Dieci Maria Vittoria, Smutná Veronika, Scott Véronique, Yin Guangliang, Xu Ran, Vielh Philippe, Mathieu Marie-Christine, Vicier Cécile, Laporte Melanie, Drusch Francoise, Guarneri Valentina, Conte Pierfranco, Delaloge Suzette, Lacroix Ludovic, Fromigué Olivia, André Fabrice, Lefebvre Celi |
|
Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing.
Clinical genetics 2016 Jan . Ng Pei Sze, Wen Wei Xiong, Fadlullah Muhammad Zaki Hidayatullah, Yoon Sook-Yee, Lee Sheau Yee, Thong Meow-Keong, Yip Cheng Har, Mohd Taib Nur Aishah, Teo Soo-Hwa |
|
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
Oncotarget 2016 Jan . Lin Po-Han, Kuo Wen-Hung, Huang Ai-Chu, Lu Yen-Shen, Lin Ching-Hung, Kuo Sung-Hsin, Wang Ming-Yang, Liu Chun-Yu, Cheng Fiona Tsui-Fen, Yeh Ming-Hsin, Li Huei-Ying, Yang Yu-Hsuan, Hsu Yu-Hua, Fan Sheng-Chih, Li Long-Yuan, Yu Sung-Liang, Chang King-Jen, Chen Pei-Lung, Ni Yen-Hsuan, Huang Chiun-She |
|
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
BMC medical genomics 2016 9 (1): 19. Mucaki Eliseos J, Caminsky Natasha G, Perri Ami M, Lu Ruipeng, Laederach Alain, Halvorsen Matthew, Knoll Joan H M, Rogan Peter |
|
BRCA1 and TP53 Gene-Mutations: Family Predisposition and Radioecological Risk of Developing Breast Cancer.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (8): 4059-62. Apsalikov Bakytbek, Manambaeva Zukhra, Ospanov Erlan, Massabayeva Meruyert, Zhabagin Kuantkan, Zhagiparova Zhanar, Maximov Vladymir, Voropaeva Elena, Apsalikov Kazbek, Belikhina Tatiana, Abdrahmanov Ramil, Cherepkova Elena, Tanatarov Sayat, Massadykov Adilzhan, Urazalina Nayl |
|
Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
Journal of experimental & clinical cancer research : CR 2016 35 (1): 135. Prodosmo Andrea, Buffone Amelia, Mattioni Manlio, Barnabei Agnese, Persichetti Agnese, De Leo Aurora, Appetecchia Marialuisa, Nicolussi Arianna, Coppa Anna, Sciacchitano Salvatore, Giordano Carolina, Pinnarò Paola, Sanguineti Giuseppe, Strigari Lidia, Alessandrini Gabriele, Facciolo Francesco, Cosimelli Maurizio, Grazi Gian Luca, Corrado Giacomo, Vizza Enrico, Giannini Giuseppe, Soddu Silv |
|
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
PloS one 2016 11 (12): e0168090. Tokunaga Eriko, Yamashita Nami, Tanaka Kimihiro, Inoue Yuka, Akiyoshi Sayuri, Saeki Hiroshi, Oki Eiji, Kitao Hiroyuki, Maehara Yoshihi |
|
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.
BMC cancer 2016 16 649. Guerra Emanuela, Cimadamore Alessia, Simeone Pasquale, Vacca Giovanna, Lattanzio Rossano, Botti Gerardo, Gatta Valentina, D'Aurora Marco, Simionati Barbara, Piantelli Mauro, Alberti Saver |
|
[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2015 Dec 32 (6): 761-5. Yang Xiaochen, Hu Zhen, Wu Jiong, Liu Guangyu, Di Genhong, Chen Canming, Hou Yifeng, Huang Xiaoyan, Liu Zhebin, Shen Zhenzhou, Shao Zhim |
|
Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Dec . Shabnaz Samia, Ahmed Maizbha Uddin, Islam Md Siddiqul, Islam Md Reazul, Al-Mamun Mir Md Abdullah, Islam Mohammad Safiqul, Hasnat Ab |
|
Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.
Breast cancer research and treatment 2015 Dec . Liang Diana H, Ensor Joe E, Liu Zhe-Bin, Patel Asmita, Patel Tejal A, Chang Jenny C, Rodriguez Angel |
|
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
Cancer 2015 Dec . Churpek Jane E, Marquez Rafael, Neistadt Barbara, Claussen Kimberly, Lee Ming K, Churpek Matthew M, Huo Dezheng, Weiner Howard, Bannerjee Mekhala, Godley Lucy A, Le Beau Michelle M, Pritchard Colin C, Walsh Tom, King Mary-Claire, Olopade Olufunmilayo I, Larson Richard |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 23, 2020
- Content source: